Mr Andrew Jane

Andrew has extensive experience relevant to our Company, including in biomedical research and development project management, marketing and business development. Andrew’s primary expertise is in the commercialization and globalization of technology based products, such as those products being developed by us. Andrew has served as a non-executive director since August 2006 and is Chairman of the Remuneration and Nomination Committee. Andrew was a director of Universal Biosensors Pty Ltd between August 15, 2006 and December 6, 2006.  In 2003, Andrew joined CM Capital Investments Pty Ltd, a Brisbane based venture capital investment company, as an Investment Manager and was promoted to Partner in 2006.  Prior to this, Andrew worked for Lake Technology, an audio technology company as Director of Business Development and Licensing, where he worked closely with Lake Technology’s strategic partner, Dolby Laboratories an audio technology company in San Francisco, and was responsible for a significant number of global licensing deals during his four years there. Prior to Lake Technology, Andrew held R&D management positions of increasing responsibility at AGEN Biomedical and the CSIRO. Andrew is currently a director of a number of life sciences companies including Advent Pharmaceuticals Pty Ltd, Altiris Therapeutics, Inc., Piedmont Pharmaceuticals, Inc., Piedmont Pharmaceuticals Pty Ltd, SpeeDx Pty Ltd and is an observer to the Board of Metastatix, Inc. and Osprey Medical, Inc. Andrew received his Master of Science in Instrumentation from the University of Manchester Institute of Science and Technology and holds a Bachelor of Science (Honors) in Physics from St Andrews University in Scotland.